Safety and efficacy of combined B-cell depleting therapy and daratumumab in patients with autoimmune encephalitis (RADIA): study protocol for a multicenter, randomized trial - Top-Institutions - MDSpire

Safety and efficacy of combined B-cell depleting therapy and daratumumab in patients with autoimmune encephalitis (RADIA): study protocol for a multicenter, randomized trial

  • By

  • Wei Xie

  • Lin-Jie Zhang

  • Chunxian Yue

  • Baojie Wang

  • Shougang Guo

  • Xuegan Lian

  • Chao Zhang

  • May 29, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Third Affiliated Hospital of Soochow University
    Third Affiliated Hospital of Soochow University

    Suzhou, Jiangsu

    Key Differentiators

    • Neurology

  • #2

    Italian hospitals
    Italian hospitals

    Various, Italy

    Key Differentiators

    • Neurology

  • #3

    University of Texas, MD Anderson Cancer Center
    University of Texas, MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Neurology

  • #4

    American Society of Hematology
    American Society of Hematology

    Washington, D.C.

    Key Differentiators

    • Hematology

  • #5

    National Cancer Institute
    National Cancer Institute

    Bethesda, Maryland

    Key Differentiators

    • Oncology

Original Source(s)

Safety and efficacy of combined B-cell depleting therapy and daratumumab in patients with autoimmune encephalitis (RADIA): study protocol for a multicenter, randomized trial

  • by Wei Xie, Lin-Jie Zhang, Chunxian Yue, Baojie Wang, Shougang Guo, Xuegan Lian, Chao Zhang

  • May 29, 2026

Related Content

Intravenous thrombolysis for acute ischemic stroke in the extended time window of 4.5–24 h: a systematic review and network meta-analysis of randomized controlled trials

Remote ischemic preconditioning in elderly patients with acute myocardial infarction and transient ischemic attack: a retrospective cohort study

Association of the neonatal sequential organ failure assessment score with neurological outcomes in infants diagnosed with hypoxic-ischemic encephalopathy